Anti-tumor necrosis factor therapy and cancer risk in patients with autoimmune disorders.
Onel
Karen B
KB
University of Chicago, Chicago, Illinois 60637, USA.
Onel
Kenan
K
D018501:Antirheumatic Agents / Q000009:adverse effects; D001327:Autoimmune Diseases / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D016867:Immunocompromised Host; D009369:Neoplasms / Q000276:immunology*; D012307:Risk Factors; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors* / Q000276:immunology
D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha